Kevin O’Brien

Kevin is TetraGenetics’ Chief Financial Officer, and has been a senior financial executive of five successive venture-financed companies that he helped grow and lead to successful exit or IPO. He was the CFO at Ahura Scientific, a manufacturer of handheld spectroscopy instruments, which grew from $1M to $70M in revenues and was sold to Thermo Fisher Scientific for approximately $190M. Prior to Ahura, Kevin was CFO at Innoveda, a software company created from a leveraged buyout that grew from $50M to $100M in revenues, went public, and ultimately sold to Mentor Graphics. He was also the Vice President of Finance at Easel Corporation, a software company that grew rapidly and had a successful IPO. Kevin has a broad operating and financial background as well as extensive experience with mergers and acquisitions.